L-199-2023
Agreement ID
L-199-2023
Lead IC
NIAID
Exclusivity
Exclusive
External Party
Leyden Laboratories BV (Marieke van der Lans)
Fiscal Year
2024
Territory
Worldwide
Execution Date
Effective Date
Export Date